Merck Gardasil Slated For Advisory Committee Review May 18
This article was originally published in The Pink Sheet Daily
Executive Summary
Vaccines & Related Biological Products committee will review HPV vaccine less than a month ahead of June 8 priority review user fee date.
You may also be interested in...
Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions
Merck will buy the monoclonal antibody developer Abmaxis and yeast glycoengineering specialist GlycoFi.
Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions
Merck will buy the monoclonal antibody developer Abmaxis and yeast glycoengineering specialist GlycoFi.
Merck Launches HPV Awareness Campaign In Preparation For Gardasil
The firm has launched television, radio and print ads although the HPV vaccine is still pending at FDA.